Cerebral gas embolism caused by pleural fibrinolytic treatment. Intrapleural fibrinolytic therapy is effective for shortening the lengths of hospital stays without increasing the incidence of severe side effects. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. Fibrinolytic therapy can be used for complicated pleural effusions or empyema without the need for operative intervention.
Patients who received intrapleural fibrinolytic therapy for symptomatic loculation between january 1, 2002, and june 30, 2014, were captured retrospectively by interrogation of the mpe, cancer, and pharmacy electronic databases at each center. Perspective intrapleural fibrinolytic therapy for empyema and pleural loculation. To describe the use of intrapleural fibrinolytic therapy. The natural history of a complicated parapneumonic effusion is to develop a single loculus or multiple loculations and then progress to an. Concurrent tpa and dnase will be administered intrapleurally through the chest tube followed by saline flush. Intrapleural fibrinolytic enzymes have been used for over 60 years in the treatment of complicated pleural effusions to lyse loculations and promote resolution. Intrapleural therapy huggins 2011 respirology wiley. Azghani,2 ann buchanan,1 jake boren,1 timothy allen,3 najib m. Rumende, zulkifli amin departement of internal medicine, faculty of medicine, university of indonesia cipto mangunkusumo hospital. Intrapleural hemorrhage after administration of tpa. Despite this extensive history of use, however, little is known about complications that may arise with the use of this therapy. Intrapleural tpa is used by some centers to restore flow of nondraining indwelling pleural catheters ipcs in symptomatic patients with malignant pleural effusions mpes. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema gurmeet singh, ceva w. Between april 1, 1990, and april 1, 1993, consecutive patients presenting with a fibrinopurulent empyema were demonstrated to have incomplete.
Accepted manuscript 1 intrapleural fibrinolytic therapy for pleural infection 1demosthenes bouros, 1argyris tzouvelekis, 2katerina m. Combined intrapleural therapy in infectious pleural effusion. Intrapleural fibrinolytic therapy is an option for the management of pleuropneumonia in horses without the need for surgical intervention, which, despite being shown to be of benefit in the treatment of the condition, is expensive and available at only a small number of specialist institutions vachon and fischer 1998. Intrapleural fibrinolytic therapy with streptokinase appears to be a safe and effective adjunctive therapy of choice and may have significant benefit even in newborns with complicated. The aim of this study is to compare the therapeutic yield of medical thoracoscopy and intrapleural. Key messages the importance of imageguided placement of drains and ct scan assessment of the loculated collections.
However, the routine use of fibrinolytic therapy cannot be recommended because the trial numbers were too small. Update on the role of intrapleural fibrinolytic therapy in. Intrapleural instillation of fibrinolytic agents for. Rahman2,3 1the department of cellular and molecular biology and the texas lung injury institute, the university of texas health science center. Jun 14, 2011 intrapleural use of a fibrinolytic agent to divide adhesions and dnase to decrease pus viscosity may promote efficient drainage of the empyema. Setting tertiary care childrens hospital in an academic medical center. Efficacy of intrapleural instillation of fibrinolytics for. Rahman,4 kathleen koenig,1 mignote chamiso,1 sophia karandashova,1 james henry,1 and steven idell1 1department of cellular and molecular biology of the university of. To study the factors associated with bleeding postfibrinolytic therapy. Dose dependency of outcomes of intrapleural fibrinolytic therapy in new rabbit empyema models andrey a. Data for 227 patients were compiled including demographics, investigations. Intrapleural fibrinolytic agents, especially urokinase, are safe, costeffective means of facilitating complete chest tube drainage, thereby avoiding the morbidity of. The utility of dnase in adults requiring pleural drainage for.
Intrapleural administration of fibrinolytic enzymes as an. Drainage of infected fluid is key to successful treatment, but intrapleural fibrinolytic therapy did not i. Komissarov, 1 galina florova, 1 ali azghani, 3 sophia karandashova, 1 anna k. Key messages the importance of imageguided placement of drains and ct. It is currently unclear how the use of intrapleural fibrinolytic therapy should be used in the context of thoracic surgery, however if a patient fails to improve after. The tube will then be clamped for 120 minutes and after which it will be connected back to wall suction. Fibrinolytic therapy versus medical thoracoscopy full. Fibrinolytic drugs are most likely to be successful in patients with early ppe. Intrapleural fibrinolytic treatment of multiloculated thoracic empyemas. Dose dependency of outcomes of intrapleural fibrinolytic. Intrapleural use of tissue plasminogen activator and dnase. Fibrinolytic therapy has recently been used in such patients in an effort to reduce the need for surgical intervention 1,36.
Objective to describe the use of intrapleural instillation of fibrinolytic agents as adjunctive therapy for children with complicated pleural effusions and empyema. Lifethreatening pleural hemorrhage following intrapleural. Clotbusting drugs for infections of the lining of the. More recent reports have increased interest in the intrapleural use of e p t novel drugs, singly or in combination with fibrinolytic drugs, that decrease the viscosity of empyema pus to promote drainage1 or interfere with the formation of intrapleural fibrous c e bands 1 2. Cerebral air embolism is an unusual potentially severe complication of this technique. Although we advocate the continued use of ipft in adult patients with pleural infection, loculation, and failed drainage, a. Intrapleural fibrinolytic therapy is often used in pediatric empyema, despite limitations with current evidence. Failure to control the pleural effusions may lead to progressive disease and can result in complicated parapneumonic effusions. Author links open overlay panel surinder janda md john swiston md. Acute multiloculated thoracic empyemas incompletely drained by tube thoracostomy alone usually require operation.
Group a 50% of patients were offered the intrapleural administration of fibrinolytic therapy in which 250,000 iu streptokinase over 100 ml normal saline was injected intrapleurally via the thoracostomy tube once daily through six days duration which then was clamped after each session for eight hours asking the patient to change his. Fibrinolytic treatment of complicated pediatric thoracic. Individual centers audited different time periods depending on the avail. Intrapleural fibrinolytic therapy ipft in loculated pleural. The natural history of a complicated parapneumonic effusion is to develop a single loculus or multiple loculations and then progress to an empyema cavity in untreated or inadequately treated. For almost 70 years, intrapleural fibrinolytic therapy ipft has been part of the therapeutic armamentarium to expedite pleural drainage in. Intrapleural fibrinolytic therapy in patients with nondraini. Contraindications for intrapleural enzyme therapy are not widely agreed upon and little is known. Intrapleural fibrinolysis for parapneumonic effusion and. The fibrinolytic therapy was given via the intrapleural catheter 814 fr or chest tube 2832 fr that was placed by interventional radiology, respirology or thoracic surgery, after which the tube was clamped for 2 h and then unclamped and placed under suction of.
Intrapleural fibrinolytic therapy for empyema and pleural. Objectives to assess risk factors associated with failure and bleeding in intrapleural fibrinolytic therapy ipft for pleural effusions. Intrapleural fibrinolytic therapy in empyema thoracis. Feb 01, 20 the fibrinolytic therapy was given via the intrapleural catheter 814 fr or chest tube 2832 fr that was placed by interventional radiology, respirology or thoracic surgery, after which the tube was clamped for 2 h and then unclamped and placed under suction of. Intrapleural instillation of fibrinolytic agents for treatme. Clotbusting drugs for infections of the lining of the lung. Background and purpose intrapleural fibrinolytic therapy is a technique used to treat empyemas and parapneumonic effusions. Given the high patient surgical risks inherent to his comorbidities, combined intrapleural therapy cit was started using a protocol similar to that explained by rahman et al. Discordance between the negative largest trial of this therapy and other studies is of concern, however, as is an absence. Addition of dornase to intrapleural fibrinolytic therapy is. The efficacy of vats and intrapleural fibrinolytic therapy in. In patients with complicated infective pleural effusion or empyema, intrapleural fibrinolytic therapy was associated with a reduction in the requirement for surgical intervention and overall treatment failure but with no evidence of change in mortality.
The use of intrapleural fibrinolysis to treat complicated pleural effusions dates back to 1949 when. Intrapleural use of a fibrinolytic agent to divide adhesions and dnase to decrease pus viscosity may promote efficient drainage of the empyema. It is safe in the majority of patients, however the most significant risk associated with this treatment is severe bleeding secondary to pleural hemorrhage. Tissue plasminogen activator tpa has been successfully used to relieve obstruction of dysfunctional devices, including vascular catheters. To avoid a thoracotomy yet treat this difficult problem, intrapleural fibrinolytic agents were employed. The role of dnase in combination with a fibrinolytic or dnase alone in the treatment of empyema will be answered by the recently completed multi. Fibrinolytic therapy was beneficial for the outcomes of treatment failure surgical intervention or death risk ratio rr, 0.
Intrapleural fibrinolytic therapy for treatment of. Participants we identified 237 cases that received ipft for the treatment of pleural effusions. Rahman, kathleen koenig, mignote chamiso, sophia karandashova, james henry, steven idell. There are multiple reports of successful 88100% efficacy ipft in adult 1, 7. Intrapleural fibrinolytic therapy ipft in loculated pleural effusions. Burkholderia pseudomallei, a soil saprophyte typically associated with the highly fatal disease melioidosis in southeast asia, is an increasing globa. Cerebral gas embolism caused by pleural fibrinolytic. Intrapleural fibrinolytic treatment with alteplase tpa and dornase alfa dnase may be considered as an adjunct to medical management in selected patients at the discretion of the respiratory consultant this guideline details the rationale, indications, contraindications and protocol for administering. Nov 11, 2019 intrapleural fibrinolytic therapy is often used in pediatric empyema, despite limitations with current evidence. Intrapleural fibrinolytic therapy agents offer a promising alternative and have been reported as an effective adjunct to accelerate drainage of loculated effusions in complicated empyema 5,11,12,14. Intrapleural fibrinolytic therapy in the management of septic. Pdf intrapleural fibrinolytic therapy for pleural infection.
Fibrinolytic therapy was a major advance in the treatment of acute stemi since 90% of stemi is due to plaque rupture and subsequent thrombus formation remains a viable option for reperfusion therapy due to the limited availability of primary pci therapy. The efficacy of vats and intrapleural fibrinolytic therapy in parapneumonic empyema treatment. The patient exhibited increased pulmonary compliance and oxygenation and was successfully separated from ecls four days after completion of tpa. Summary of case a patient with parapneumonic pleural effusion underwent pleural lavage with streptokinase when he suddenly demonstrated focal. Intrapleural fibrinolysis during pediatric extracorporeal. Intrapleural use of tissue plasminogen activator and dnase in. Emp generally occurs with pleural loculation and impaired drainage is often treated with intrapleural fibrinolytic therapy ipft or. Intrapleural fibrinolysis, pneumonia, empyema, effusion, vats. All patients who received intrapleural fi brinolytic therapy for symptomatic loculations between january 1, 2002, and june 30, 2014, in four established ipc centers were retrospectively included.
Despite this extensive history of use, however, little is known about complications that may arise with the. Intrapleural fibrinolytic therapy for pleural infection. Fibrinolytic agents are believed to work through decreasing fibrinous strands and reopening pleural pores blocked by fibrinous material. Pleural effusions are common complications of pediatric bacterial pneumonias. Intrapleural fibrinolytic agents, especially urokinase, are safe, costeffective means of facilitating complete chest tube drainage, thereby avoiding the morbidity of a major thoracotomy for 77%. To assess the safety and efficacy of urokinase and alteplase for intrapleural fibrinolysis in children with parapneumonic pleural fluid collections. Heffner 1department of pneumonology, medical school, democritus university of thrace, alexandroupolis, greece. This stage requires pleural space drainage along with either instillations of intrapleural fibrinolytics or vats apart from appropriate antibiotics. In this issue of jama pediatrics, livingston et al 1 address the important question of whether a therapy demonstrated to improve the care of adult patients with empyema, the addition of dornase alfa dnase to tissue plasminogen activator tpa intrapleural therapy, has similar benefits in children. Although we advocate the continued use of ipft in adult patients with pleural infection, loculation, and failed drainage, a number of controversial points remain. Rahman,4 kathleen koenig,1 mignote chamiso,1 sophia karandashova,1 james henry,1 and steven idell1. The present results show that intrapleural fibrinolysis with urokinase may be potentially effective for reducing the need for surgery.
Rahman2,3 1the department of cellular and molecular biology and the texas lung injury institute, the university of texas health science center at tyler, tyler, texas. The incidence of empyema emp is increasing worldwide. There are few welldesigned trials in children and most studies are prospective or retrospective observational reports with great diversity in the age of included children, type of fibrinolytic, timing of administration, number of doses, and outcomes evaluated. Intrapleural fibrinolytic therapy in a neonate, indian. During the 72 hours of fibrinolytic therapy, cumulative pleural drainage was 300 ml 15 mlkg and serial chest radiographs confirmed reduced volume of intrapleural hematoma and improved lung aeration. Intrapleural fibrinolytic therapy in loculated effusions.
Intrapleural fibrinolytic treatment of pleural space sepsis was first described in 1949 when tillett and sherry published their seminal article on this subject using streptokinase. Intrapleural fibrinolytic therapy in a neonate request pdf. Intrapleural fibrinolysis for the treatment of indwelling. Intrapleural fibrinolytic agents, especially urokinase, are safe, costeffective means of facilitating complete chest tube drainage, thereby avoiding the morbidity of a major thoracotomy for 77% of a group multiloculated empy ema patients who traditionally would have required open surgical therapy. The intrapleural therapy will be given twice daily for a maximum of 6 doses. Intrapleural fibrinolytic therapy in a neonate springerlink. Intrapleural fibrinolytic therapy in the management of. Active macroglobulin is a reservoir for urokinase after.
Intrapleural fibrinolytic therapy remains an option for poor surgical candidates who fail chest tube drainage or who require a period of medical stabilization before surgery is performed. Although we advocate the continued use of ipft in adult patients with pleural infection. Intrapleural fibrinolytic therapy in patients with. The dose of intrapleural tpa 2 mg, frequency of administration every 24 hours, and duration of therapy 72 hours, for both patients were selected based on our institutional experience with fibrinolysis for pleural space infections and are consistent with dosing strategies from limited reports of intrapleural fibrinolysis for retained. Intrapleural tpa and dnase in pleural infection n engl j med 365. Intrapleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas. Intrapleural fibrinolytic enzyme therapy is a potentially surgerysparing treatment for poorly resolving parapneumonic effusion and empyema. We studied 97 patients with mpe and a nondraining ipc in the setting of persistent pleural fluid who were treated with intrapleural tpa.
Intrapleural fibrinolytic therapy ipft in loculated. Contraindications for intrapleural enzyme therapy are not widely agreed. Because few studies have evaluated its safety and effectiveness, we conducted a retrospective cohort study of outcomes after tpa treatment during a 10year period at our institution. Reperfusion therapy for acute myocardial infarction. To study the factors associated with failure of therapy. Forest plot for outcome of surgical intervention for fibrinolytic therapy vs placebo for loculated pleural effusions only. Azghani, ann buchanan, jake boren, timothy allen, najib m. Intrapleural instillation of fibrinolytic agents has been found to be a useful. Intrapleural fibrinolytic therapy for treatment of adult. Intrapleural fibrinolytic therapy in a neonate intrapleural fibrinolytic therapy in a neonate narayan prasad, amarendra 20110901 00. Pdf the efficacy of vats and intrapleural fibrinolytic. In our clinic, we used intrapleural fibrinolytic agents in 72 pediatric patients with multiloculated empyema between 1994 and 2002.
596 112 75 1204 990 1151 809 1037 1261 1301 1405 711 315 342 1273 381 888 388 1114 201 873 1402 1227 1550 972 501 1113 849 606 1283 25 1377 1064 615 690 648 825 1303 465 622